MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy
MicroRNAs are a set of highly conserved non-coding RNAs that control gene expression at the post-transcriptional/translational levels by binding to the 3′-UTR of diverse target genes. Increasing evidence indicates that miRNAs not only play a vital role in many biological processes, but they are also...
Main Authors: | Yuanyuan Liang, Shun Li, Liling Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/6/591 |
Similar Items
-
MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
by: Lu Zhang, et al.
Published: (2019-02-01) -
Rotavirus Induces Epithelial–Mesenchymal Transition Markers by Transcriptional Suppression of miRNA-29b
by: Urbi Mukhopadhyay, et al.
Published: (2021-02-01) -
miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy
by: Prashanth K. B. Nagesh, et al.
Published: (2018-08-01) -
Circulating microRNA (miRNA) Expression Profiling in Plasma of Patients with Gestational Diabetes Mellitus Reveals Upregulation of miRNA miR-330-3p
by: Guido Sebastiani, et al.
Published: (2017-12-01) -
miR-34 – A microRNA Replacement Therapy Is Headed to the Clinic
by: Andreas G Bader
Published: (2012-07-01)